The evidence is constructive, but security selection and entry discipline still matter.
61
technical evidence
out of 100
out of 100
Week Ending: 28 August 2026
United States US Healthcare Industry
Medical Instruments & Supplies
For the week ending 28 August 2026, Medical Instruments & Supplies declined 0.41% with 19 advancing, 30 declining, and 1 unchanged constituents. The index is equal weighted and the constituent tape shows uncapped security returns.
Current architecture
Upward Expansion
The activity fan is positively ordered above a rising Trend Line with price accepted above it.
61
technical evidence
Index966.41
1 week-0.41%
Breadth38%
Members50
Country
🇺🇸 United States · US
Sector
Healthcare
Universe
NASDAQ, NYSE
Price basis
Adjusted weekly close
Trend architecture
Index, activity fan and structural anchors
Rolling 156-week evidence. Trend Signal points mark weeks when price, trend and the activity fan confirmed together.
Index Value
Trend Line
Fair Value
Activity Lines
Constructive architecture
Transitional architecture
Defensive architecture
Current architecture
Upward Expansion
3 completed weeks in this state
Trend acceptance
7.9%
Index versus Trend Line
Persistence
50%
Negative regime, shorter trend repairing
Participation
38%
19 advancing, 30 declining
Investor positioning lens
Is the evidence ready for capital?
A rules-based technical classification using trend, breadth, persistence, relative strength and path quality.
Evidence balance
Selective
Five-pillar map
Trend
71
Breadth
46
Persistence
56
Relative
55
Risk quality
88
What supports the view
- The index remains above a constructive Trend gate.
- Constituent trends show positive multi-horizon persistence.
What restrains conviction
- Breadth remains too narrow or inconsistent for a high-conviction position.
- The group is not yet delivering dependable relative outperformance.
- Positive contribution is concentrated in a small leadership cohort.
This is a weekly research classification, not personal investment advice. Sentiment is reported as an independent confirmation layer and does not alter the technical score.
Trend state and durability
Architecture, persistence and constituent regimes
The index path is tested against the underlying security-level trend evidence.
The activity fan is positively ordered above a rising Trend Line with price accepted above it.
State age3 weeks
Trend gateUp
Fan width5.96%
Fast versus slow change2.21 pts
Above 83%
Below 17%
Six completed weeks of price acceptance relative to the full Activity Line fan.
Index persistence
50% agreement
Negative regime, shorter trend repairing
The long trend remains negative, but shorter-horizon repair is now visible.
13-week
8.0%
26-week
3.5%
39-week
-0.2%
52-week
-1.4%
Constituent trend persistence
98% coverage
Is the index move broadly durable?
53%positive
Coherent positive31%
Coherent negative22%
Average horizon agreement85%
Positive horizon share56%
Weakening positives3
Repairing negatives6
49 constituents measured as of 28 Aug 2026. Median trend age is 17 weeks.
Custom stage map
94% coverage
Where constituents sit in the cycle
32%Stage 1
Stage 1 · Basing32%15 securities
Stage 2 · Advancing30%14 securities
Stage 3 · Distribution6%3 securities
Stage 4 · Declining32%15 securities
Re-acceleration watch1
Transition watch7
Relative strength leaders36%
Fair Value repairs8
Measured as of 28 Aug 2026. Stages summarize price, Activity Line architecture, Fair Value position and relative evidence.
Architecture breadth
76/100 mean confidence
How market energy is distributed
Architecture breadth shows the distribution of expanding, rotating, balancing and contracting securities. It is diagnostic context and is not added as a second vote in the positioning score.
Capital rotation
Performance relative to Healthcare
Relative index
13-week relative trend
Starting level
A rising relative line means this group is compounding faster than Healthcare. A falling line means capital has done better in the parent benchmark.
Relative index95.1
13-week trend93.8
4-week trend change1.57%
Weekly peer rank4 of 11
1 week
0.9 pts
relative
4 weeks
-2.6 pts
relative
13 weeks
4.1 pts
relative
26 weeks
-0.2 pts
relative
52 weeks
-11.7 pts
relative
Market internals
Participation, dispersion and path risk
Equal-weight index evidence with constituent-level breadth and dispersion.
Breadth
Narrow
Participation quality
38%
advanced
- Advancing
- 19
- Declining
- 30
- Unchanged
- 1
Risk and persistence
52-week lens
Path quality
Annualised weekly volatility19.8%
Drawdown from 52-week high-2.5%
Positive weeks, last 1346%
Current directional run2 weeks
Turnover versus 13-week norm126%
Breadth impulse-17.3 pts
Cross-section
50 measured
Return distribution
Q1 -3.4%
Median -1.1%
Q3 1.5%
Average winner5.6%
Average loser-3.7%
Dispersion7.3 pts
Top-five upside share73%
Top-five capital share63%
Capital data coverage100%
Dispersion describes how far constituent outcomes are spreading apart. Capital concentration is contextual only; the index itself is equal weighted.
Momentum cycle
30-week persistence
Positive readings show expansion. Negative readings show contraction.
Breadth cycle
Net participation
Advancers less decliners as a percentage of measured constituents.
News and narrative
Does company news confirm the market tape?
52out of 100
Mixed
Positive and negative company-news scores are balancing each other.
Evidence quality
44/100 confidence
Coverage before conviction
Qualified companies714% of measured constituents
Articles508100% direct company evidence
Publishers133Independent sources represented
Latest evidence1 SepFreshness is weighted in the score
Constructive 14%Balanced 71%Cautious 14%
Price confirms news2
Price disagrees0
Negative news absorbed0
Positive but stretched0
Constructive edge
Strongest qualified tone
RMD58/100 confidence · 115 direct
58
KeyBanc Adjusts Price Target on ResMed to $267 From $255, Keeps Overweight Rating
TFX35/100 confidence · 61 direct 56Teleflex (TFX) Stock Trades At A Discount On Cash Flow But A Premium On Sales
ALGN38/100 confidence · 61 direct 54Quentin Blackford to Join Align Technology Board of Directors
AVTR41/100 confidence · 43 direct 53How Investors May Respond To Avantor (AVTR) Leadership Transition And Raised 2026 Guidance
ISRG42/100 confidence · 102 direct 52Intuitive Surgical stock holds above $372 as investors weigh recent valuation resets
Narrative risk
Weakest qualified tone
EMBC51/100 confidence · 70 direct
34
Embecta: Excellent Turnaround Prospect In Defensive Medical Products
BAX38/100 confidence · 56 direct 46Fiberglass in IV saline? Texas among states included in recall
ISRG42/100 confidence · 102 direct 52Intuitive Surgical stock holds above $372 as investors weigh recent valuation resets
AVTR41/100 confidence · 43 direct 53How Investors May Respond To Avantor (AVTR) Leadership Transition And Raised 2026 Guidance
ALGN38/100 confidence · 61 direct 54Quentin Blackford to Join Align Technology Board of Directors
Only fresh, quality-controlled company evidence is included. Industry and sector context is down-weighted and cannot create a directional group conclusion on its own.
Leadership tape
Leaders, laggards and contribution shape
Latest completed week, ranked on uncapped constituent returns.
Constituent ledger
Industry constituents
All 50 measured constituents, ranked by latest weekly return.
Rank
Ticker
Company
Exchange
Market cap
Close
Index contribution
Return
The index uses capped equal-weight weekly constituent returns. The ledger shows uncapped security returns so outliers remain visible for research.